Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: August 21, 2024
Reporting Period: The filing reports on a milestone achieved as of June 30, 2024.
Key Financial Metrics
This Form 8-K is a disclosure of a business milestone and does not contain audited financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing text does not provide a clear value for these financial indicators.
Material Changes
The primary material event disclosed is a significant operational milestone:
- Installed Base: The Company announced it has achieved over 1,000 installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) detailing the milestone. The disclosure is qualified in its entirety by the full text of that press release.
Legal Status: The information in Item 7.01 is furnished and not deemed "filed" under the Exchange Act, nor is it incorporated by reference into other filings unless specifically identified.
Risks and Contingencies: No specific risks, contingencies, or forward-looking guidance are detailed within the text of this 8-K summary.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) for details on the 1,000+ installed readers milestone.
- Review the Company's most recent 10-Q or 10-K for actual financial performance data, as this 8-K contains no financial metrics.
- Confirm the trading status of Common Stock (Symbol: INBS) on The Nasdaq Stock Market LLC.
- Note that the Company is classified as an "Emerging Growth Company."